| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K52037352 |
| PharmacoGx | BRD-K52037352 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TRPV5 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | CD163L1 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | FGF4 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | SLC25A22 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | HIST1H2AM | CTRPv2 | pan-cancer | AAC | 0.097 | 0.02 |
| mRNA | AP3B1 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | GCK | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | GPX8 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | MAPKAPK2 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.02 |
| mRNA | UBQLN4 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.02 |
